Statistics from Altmetric.com
Li W, Wu Y, Li X, et al. Intravenous tirofiban therapy for patients with capsular warning syndrome. Stroke Vasc Neurol 2019. doi: 10.1136/svn-2018-000163. [Epub ahead of print 9 Jan 2019].
In the Results section of the Abstract, “After treatment, in T-group, four patients (26.7%) had recurrent attacks, and NIHSS scores were in 11 patients (73.3%) at 24 hours” should read “After treatment, in T-group, four patients (26.7%) had recurrent attacks, and NIHSS scores were 0 in 11 patients (73.3%) at 24 hours.”
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.